News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
David Heredia: Osimertinib + Chemotherapy Offers a Statistically Significant
Photo: drdavidherediav.com
Jul 22, 2025, 10:54

David Heredia: Osimertinib + Chemotherapy Offers a Statistically Significant

David Heredia, Head of Oncology Department at Punta Médica Hospital, shared on X:

“Press Release. FLAURA2 OS Results

Longer follow-up confirms that osimertinib + chemo offers a statistically significant and clinically meaningful OS benefit over osimertinib alone in 1L EGFRm NSCLC. Reinforces osimertinib as the backbone across stages. Follows the longest-reported PFS in this setting

Looking forward to seeing the full data soon!”

More posts featuring NSCLC.

cancer David Heredia Lung cancer NSCLC OncoDaily Oncology
Special Coverage
Blog
Jul 22, 2025, 10:54
David Heredia: Osimertinib + Chemotherapy Offers a Statistically Significant
Career
Jul 22, 2025, 10:49
In Memoriam: Bill Gerber - First Selectman of Fairfield(1964–2025)
Blog
Jul 22, 2025, 10:38
The 8th Annual Meeting of the IACH
Insight
Jul 22, 2025, 10:22
Nieves Martinez Lago: Early-Onset GI Cancers
Blog
Jul 22, 2025, 09:59
Isabel Mestres: Same Place. Same People. Grown Eyes. New Mission
Blog
Jul 22, 2025, 09:52
Who Says Life Slows Down After a Cancer Diagnosis? - The Max Foundation
Blog
Jul 22, 2025, 09:50
National Cancer Summit
Blog
Jul 22, 2025, 09:34
Why was the TRUST trial conducted? - European Society of Gynaecological Oncology
Blog
Jul 22, 2025, 09:31
David Skorton: The AAMC CHARGE Community Is Seeking Ambassadors to Join Collaborative for Health Equity
Blog
Jul 22, 2025, 09:24
Mohit Manrao: Closer to Our Goal of Eliminating Cancer as a Cause of Death
Blog
Jul 22, 2025, 08:54
Nita Radhakrishnan: National Training Program on Early Diagnosis and Referral of Children with Cancers
Insight
Jul 22, 2025, 08:51
Hassan R. Hashmi: ISR-CAA vs APR in Non-cCR Distal Rectal Cancer